The Dynamiclear Clinical Trial has been peer-reviewed by an independent panel of experts  and the findings have now been published in the prestigious Journal of Drugs in Dermatology (New York), February 2012, Issue 11, Volume 2.
The publication demonstrates the promising potential of Dynamiclear as a single application treatment for relief of Herpes simplex virus (HSV-1 and HSV-2) symptoms.
Dynamiclear was shown to heal HSV-1 and HSV-2 symptoms faster than the comparator product Acyclovir, with the added benefit of only requiring a SINGLE APPLICATION.
Not multiple applications for multiple days.
1. The Dynamiclear clinical trial has been peer-reviewed by Amy Clewell ND, Matt Barnes MS, John R. Endres ND, Mansoor Ahmed PhD and Daljit K. S. Ghambeer MD.
Find out more information on how Dynamiclear can help you.